Showing results (11-20 of 247) with videos related to
Sort By:
Pageof 25
Experimental Neurology|June 1, 1986
Microwave irradiation of peripheral nerve following injury: a structural analysis of degeneration and regenerationJ M Kerns, H P WeinribClinical Pharmacology in Drug Development|May 10, 2025
A 2-Part, Open-Label, Phase 1 Bioequivalence and Food-Effect Study of Ubrogepant in Healthy Adult ParticipantsRamesh Boinpally, Joel M TrugmanCanadian Journal of Pain = Revue Canadienne De La Douleur|January 10, 2022
Chronic postsurgical pain: From risk factor identification to multidisciplinary management at the Toronto General Hospital Transitional Pain ServiceJoel Katz, Aliza Z Weinrib, Hance ClarkeMicrosurgery|January 1, 1983
The external ring method of microvenous anastomosis: a new experimental conceptH Weinrib, R R Schenck, B SadrThe Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 1, 1987
Selective D1 and D2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesionsJ M Trugman, G F WootenBrain Research|April 2, 1993
D1 dopamine agonist and antagonist effects on regional cerebral glucose utilization in rats with intact dopaminergic innervationJ M Trugman, C L JamesClinical and Translational Science|January 24, 2024
Ubrogepant: Mechanism of action, clinical and translational scienceRamesh Boinpally, Mohamad Shebley, Joel TrugmanNeuropharmacology|June 1, 1989
The dopamine agonist, PHNO ((+)-4-propyl-9-hydroxynaphthoxazine), inhibits cyclic adenosine 3',5'-monophosphate formation and prolactin release from anterior pituitary cellsI S Login, J M TrugmanPhysical Review Letters|December 17, 2004
Exact ground states of a frustrated 2D magnet: deconfined fractional excitations at a first-order quantum phase transitionC D Batista, S A TrugmanPageof 25